Chrysostomakis Stavros I, Simantirakis Emmanuel N, Schiza Sophia E, Karalis Ioannis K, Klapsinos Nikolaos C, Siafakas Nikolaos M, Vardas Panos E
Department of Cardiology, University Hospital of Heraklion, Crete, Greece.
Hellenic J Cardiol. 2006 Jan-Feb;47(1):13-20.
Sleep apnoea, which constitutes a major social problem because of its high prevalence and its emerging association with cardiovascular morbidity and mortality, is known to affect autonomic nervous system activity. We assessed the hypothesis that treatment of sleep apnoea patients with continuous positive airway pressure (CPAP) alters the indices of heart rate variability (HRV) that reflect sympathetic and parasympathetic autonomic nervous system activity.
We studied 26 patients (18 men, aged 49.2 +/- 7.6 years) with obstructive sleep apnoea-hypopnoea syndrome. In all patients, a 24-hour Holter recording was obtained one week before initiation of CPAP treatment and another one two months later. From these recordings we assessed the time domain indices of HRV (pNN50, rMSSD, SDNN, SDANN, SD) during the day (08:00-23:00) and during the night hours (23:00-08:00) as well as their post-treatment changes. The same HRV indices were also assessed in a group of 19 age and sex matched controls, without sleep apnoea.
No significant differences in the HRV indices were observed during the daytime hours, while during the night both pNN50 and rMSSD were significantly higher in patients compared to controls (19.5 +/- 12.5 vs. 13.8 +/- 9.7, p=0.001, for pNN50 and 54.7 +/- 23.1 vs. 44.0 +/- 15.9, p=0.001, for rMSSD, for patients and controls respectively). No such differences were observed in any of the monitored indices following CPAP treatment.
The indices that reflect parasympathetic activity are increased during the night in patients with obstructive sleep apnoea syndrome. CPAP treatment reduces the night time vagal indices of HRV to resemble those of normal controls. The reduction of parasympathetic activity may be one of the mechanisms responsible for the alleviation of bradyarrhythmic episodes following the initiation of CPAP therapy.
睡眠呼吸暂停因其高患病率以及与心血管疾病发病率和死亡率之间日益显现的关联而成为一个重大社会问题,已知其会影响自主神经系统活动。我们评估了以下假设:使用持续气道正压通气(CPAP)治疗睡眠呼吸暂停患者会改变反映交感和副交感自主神经系统活动的心率变异性(HRV)指标。
我们研究了26例(18名男性,年龄49.2±7.6岁)阻塞性睡眠呼吸暂停低通气综合征患者。所有患者在开始CPAP治疗前一周以及两个月后分别进行一次24小时动态心电图记录。从这些记录中,我们评估白天(08:00 - 23:00)和夜间(23:00 - 08:00)HRV的时域指标(pNN50、rMSSD、SDNN、SDANN、SD)以及治疗后的变化。还对一组19名年龄和性别匹配、无睡眠呼吸暂停的对照组进行了相同的HRV指标评估。
白天HRV指标未观察到显著差异,而夜间患者的pNN50和rMSSD均显著高于对照组(pNN50分别为19.5±12.5和13.8±9.7,p = 0.001;rMSSD分别为54.7±23.1和44.0±15.9,p = 0.001,分别为患者组和对照组)。CPAP治疗后,在任何监测指标中均未观察到此类差异。
阻塞性睡眠呼吸暂停综合征患者夜间反映副交感神经活动的指标升高。CPAP治疗可降低HRV的夜间迷走神经指标,使其类似于正常对照组。副交感神经活动的降低可能是CPAP治疗开始后缓解缓慢性心律失常发作的机制之一。